keyword
https://read.qxmd.com/read/38625820/improvement-of-quality-of-care-provided-to-outpatients-with-hepatic-cirrhosis-after-an-educational-intervention
#1
JOURNAL ARTICLE
Alberto Amador, Silvia Salord, Xavier Xiol, Marta Garcia-Guix, Alba Cachero, Rosa Rota, Nerea Hernandez Aretxabaleta, Carme Baliellas, Jose Castellote
OBJECTIVE: A set of indicators has been reported to measure the quality of care for cirrhotic patients, and previously published studies report variable adherence rates to these indicators. This study aimed to assess the quality of care provided to cirrhotic outpatients before and after an educational intervention by determining its impact on adherence to quality indicators. METHODS: We conducted a quasi-experimental, cross-sectional study including 324 cirrhotic patients seen in 2017 and 2019 at a tertiary teaching hospital in Spain...
April 15, 2024: European Journal of Gastroenterology & Hepatology
https://read.qxmd.com/read/38622855/treatment-of-cavernous-transformation-of-portal-vein-caused-by-hepatic-cystic-echinococcosis-using-ex-vivo-liver-resection-and-autotransplantation
#2
JOURNAL ARTICLE
Ayidu Reyimu, Jiang Tiemin, Shao Yingmei, Zhu Xuepeng, Guo Wenjiang, Du Yuhao, Dilixiati Halimulati, Wusiman Ababokeli, Aji Tuerganaili, Wen Hao
BACKGROUND Hepatic cystic echinococcosis (HCE) is a frequently overlooked parasitic liver disease, for which the commonly recommended treatment is radical resection. However, this approach is often associated with severe comorbidities such as HBV/HCV, cirrhosis, and hepatic carcinoma, among others. CASE REPORT In this report, we present a case successfully managed by ex vivo liver resection and autologous liver transplantation (ELRA). In the described case, ex vivo resection was not feasible due to recurrent lesions and infections invading the portal vein, which resulted in portal vein cavernous transformation...
April 16, 2024: Annals of Transplantation: Quarterly of the Polish Transplantation Society
https://read.qxmd.com/read/38622271/ocular-manifestations-of-liver-disease-an-important-diagnostic-aid
#3
REVIEW
Riya Patel, Smriti Nair, Hassaam Choudhry, Mustafa Jaffry, Mohammad Dastjerdi
PURPOSE: This review examined existing literature to determine various ocular manifestations of liver pathologies, with a focus on metabolic deficiencies as well as viral and immune liver conditions. METHODS: Recent data were compiled from PubMed from 2000 to 2020 using keywords that were relevant to the assessed pathologies. Ocular presentations of several liver pathologies were researched and then summarized in a comprehensive form. RESULTS: Several ocular manifestations of liver disease were related to vitamin A deficiency, as liver disease is associated with impaired vitamin A homeostasis...
April 15, 2024: International Ophthalmology
https://read.qxmd.com/read/38616573/intraoperative-renal-replacement-therapy-during-liver-transplantation-in-children-safety-efficacy-and-impact-on-survival
#4
JOURNAL ARTICLE
Kristin J Dolan, Ayse Arikan, Anna M Banc-Husu, Muhammad Umair Mukhtar Mian, Sameer Thadani, Jeffrey Quinn Lee, Lacey Stribling, N Thao N Galván, John Goss, Rahul Baijal, Moreshwar S Desai
BACKGROUND: Intraoperative Continuous Renal Replacement Therapy (iCRRT) can prevent life-threatening complications, facilitate fluid management, and maintain metabolic homeostasis during liver transplantation (LT) in adults. There is a paucity of data in pediatric LT. We evaluated the safety, efficacy, and impact on survival of iCRRT in pediatric LT. METHODS: We conducted a retrospective cohort study of all children requiring CRRT pre-OLT at a quaternary children's hospital from 2014 to 2022...
April 2024: Clinical Transplantation
https://read.qxmd.com/read/38616470/underfunding-of-german-university-based-high-performance-medicine-exemplified-by-the-treatment-of-varices-in-cirrhosis
#5
JOURNAL ARTICLE
Simone Claus, Jonathan F Brozat, Christian Trautwein, Alexander Koch
Facing increasing economization in the health care sector, clinicians have to adapt not only to the ever-growing economic challenges, but also to a patient-oriented health care. Treatment costs are the most important variable for optimizing success when facing scarce human resources, increasing material- and infrastructure costs in general, as well as low revenue flexibility due to flat rates per case in Germany, the so-called Diagnosis-Related Groups (DRG). University hospitals treat many patients with particularly serious illnesses...
April 13, 2024: Zeitschrift Für Evidenz, Fortbildung und Qualität Im Gesundheitswesen
https://read.qxmd.com/read/38616454/does-the-use-of-viscoelastic-hemostatic-assays-for-periprocedural-hemostasis-management-in-liver-disease-improve-clinical-outcomes
#6
JOURNAL ARTICLE
Suzanne Maynard, Elizabeth Marrinan, Lara Roberts, Simon Stanworth
Routine hemostasis parameters such as prothrombin time and fibrinogen are frequently abnormal in patients with chronic liver disease and have been demonstrated to be poor predictors for periprocedural bleeding. Alterations in procoagulant and anticoagulant factors in this population result in a state of rebalanced hemostasis, which is not reflected by routine hemostatic measures. Viscoelastic hemostatic assays (VHA) present a point of care measure of global hemostasis with an emerging role in guiding transfusion in the liver transplant setting...
March 19, 2024: Transfusion Medicine Reviews
https://read.qxmd.com/read/38616215/organizational-and-implementation-factors-associated-with-cirrhosis-care-in-the-veterans-health-administration
#7
JOURNAL ARTICLE
Heather McCurdy, Anna Nobbe, Dawn Scott, Heather Patton, Timothy R Morgan, Jasmohan S Bajaj, Vera Yakovchenko, Monica Merante, Sandra Gibson, Carolyn Lamorte, Gyorgy Baffy, George N Ioannou, Tamar H Taddei, Karine Rozenberg-Ben-Dror, Jennifer Anwar, Jason A Dominitz, Shari S Rogal
BACKGROUND: The Veterans Health Administration provides care to more than 100,000 Veterans with cirrhosis. AIMS: This implementation evaluation aimed to understand organizational resources and barriers associated with cirrhosis care. METHODS: Clinicians across 145 Department of Veterans Affairs (VA) medical centers (VAMCs) were surveyed in 2022 about implementing guideline-concordant cirrhosis care. VA Corporate Data Warehouse data were used to assess VAMC performance on two national cirrhosis quality measures: HCC surveillance and esophageal variceal surveillance or treatment (EVST)...
April 14, 2024: Digestive Diseases and Sciences
https://read.qxmd.com/read/38614656/recent-treatment-advances-and-practical-management-of-hepatitis-d-virus
#8
REVIEW
Kathryn Olsen, Sara Mahgoub, Sarah Al-Shakhshir, Akram Algieder, Sowsan Atabani, Ayman Bannaga, Ahmed M Elsharkawy
Hepatitis D virus (HDV), also referred to as hepatitis delta virus, is the smallest virus capable of causing human disease. It is unable to replicate on its own and can only propagate in the presence of hepatitis B virus (HBV). Infection with both HBV and HDV frequently results in more severe disease than HBV alone, with higher instances of cirrhosis, liver failure and hepatocellular carcinoma (HCC). Thus, there is a need for effective treatment for HDV; however, currently approved treatment options are very limited both in terms of their efficacy and availability...
July 2023: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38613172/plant-derived-flavonoids-are-a-potential-source-of-drugs-for-the-treatment-of-liver-fibrosis
#9
REVIEW
Bolin Zhao, Kai Liu, Xing Liu, Qiuxia Li, Zhibei Li, Jingjing Xi, Fan Xie, Xiaofang Li
Liver fibrosis is a dynamic pathological process that can be triggered by any chronic liver injury. If left unaddressed, it will inevitably progress to the severe outcomes of liver cirrhosis or even hepatocellular carcinoma. In the past few years, the prevalence and fatality of hepatic fibrosis have been steadily rising on a global scale. As a result of its intricate pathogenesis, the quest for pharmacological interventions targeting liver fibrosis has remained a formidable challenge. Currently, no pharmaceuticals are exhibiting substantial clinical efficacy in the management of hepatic fibrosis...
April 12, 2024: Phytotherapy Research: PTR
https://read.qxmd.com/read/38607390/albumin-a-comprehensive-review-and-practical-guideline-for-clinical-use
#10
JOURNAL ARTICLE
Farshad Abedi, Batool Zarei, Sepideh Elyasi
PURPOSE: Nowadays, it is largely accepted that albumin should not be used in hypoalbuminemia or for nutritional purpose. The most discussed indication of albumin at present is the resuscitation in shock states, especially distributive shocks such as septic shock. The main evidence-based indication is also liver disease. In this review, we provided updated evidence-based instruction for definite and potential indications of albumin administration in clinical practice, with appropriate dosing and duration...
April 12, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/38601721/bilothorax-a-rare-complication-of-percutaneous-transhepatic-biliary-drainage-in-a-patient-with-primary-sclerosing-cholangitis
#11
Temitope Olasehinde, Nathan Stehouwer
Bilothorax is a rare etiology of pleural effusions that involves leakage of bile from the biliary system into the pleural cavity. Most cases result from iatrogenic mechanisms, like endoscopic retrograde cholangiopancreatography. However, only a limited number of cases have reported this as a complication of percutaneous transhepatic biliary drainage. We report this rare presentation in an elderly man with primary sclerosing cholangitis after receiving percutaneous transhepatic biliary drainage for decompression of multiple complex biliary obstructions...
April 2024: ACG Case Reports Journal
https://read.qxmd.com/read/38600006/guidelines-for-the-management-of-coagulation-disorders-in-patients-with-cirrhosis
#12
I Aiza-Haddad, L E Cisneros-Garza, O Morales-Gutiérrez, R Malé-Velázquez, M T Rizo-Robles, R Alvarado-Reyes, L A Barrientos-Quintanilla, F Betancourt-Sánchez, E Cerda-Reyes, R Contreras-Omaña, M B Dehesa-Violante, N C Flores-García, D Gómez-Almaguer, M F Higuera-de la Tijera, M A Lira-Pedrin, J E Lira-Vera, H Manzano-Cortés, D E Meléndez-Mena, M R Muñoz-Ramírez, J L Pérez-Hernández, M V Ramos-Gómez, J F Sánchez-Ávila
Coagulation management in the patient with cirrhosis has undergone a significant transformation since the beginning of this century, with the concept of a rebalancing between procoagulant and anticoagulant factors. The paradigm that patients with cirrhosis have a greater bleeding tendency has changed, as a result of this rebalancing. In addition, it has brought to light the presence of complications related to thrombotic events in this group of patients. These guidelines detail aspects related to pathophysiologic mechanisms that intervene in the maintenance of hemostasis in the patient with cirrhosis, the relevance of portal hypertension, mechanical factors for the development of bleeding, modifications in the hepatic synthesis of coagulation factors, and the changes in the reticuloendothelial system in acute hepatic decompensation and acute-on-chronic liver failure...
April 9, 2024: Revista de Gastroenterología de México
https://read.qxmd.com/read/38598544/trends-in-transcatheter-aortic-valve-implantation-utilization-outcomes-and-healthcare-resource-use-in-patients-with-liver-cirrhosis-a-decade-of-insights-2011-2020
#13
JOURNAL ARTICLE
Chayakrit Krittanawong, Yichen Wang, Yusuf Kamran Qadeer, Bing Chen, Zhen Wang, Fu'ad Al-Azzam, Mahboob Alam, Samin Sharma, Hani Jneid
It is well known that individuals with liver cirrhosis are considered high risk for cardiac surgery, with an increased risk for morbidity and mortality as the liver disease progresses. In the last decade, there have been considerable advances in transcatheter aortic valve implantation (TAVI) as an alternative to surgical aortic valve replacement (SAVR) in individuals deemed to high risk for surgery. However, research surrounding TAVI in the setting of liver cirrhosis has not been as widely studied. In this national population-based cohort study, we evaluated the trends of mortality, complications, and healthcare utilization in liver cirrhotic patients undergoing TAVI, as well as analyze the basic demographics of these individuals...
April 8, 2024: Critical Pathways in Cardiology
https://read.qxmd.com/read/38596805/inpatient-screening-brief-intervention-and-referral-to-treatment-for-alcohol-use-disorder-in-patients-admitted-with-alcohol-associated-liver-disease-is-not-universally-implemented-in-practice-but-can-reduce-readmissions-for-alcohol-associated-hepatitis
#14
JOURNAL ARTICLE
Dennis Wang, Marco Puglia
INTRODUCTION: The management of alcohol-related liver disease requires a multidisciplinary approach to treat alcohol use disorder. We aimed to determine the proportion of actively drinking patients admitted for alcohol-associated hepatitis (AAH) or decompensated alcohol-related cirrhosis (DARLC) who were offered or underwent screening, brief intervention, and referral to treatment (SBIRT) for alcohol use disorder during admission and if inpatient SBIRT is associated with reduced readmissions for alcohol-related liver disease...
April 2024: Journal of the Canadian Association of Gastroenterology
https://read.qxmd.com/read/38596498/optimizing-nutrition-in-hepatic-cirrhosis-a-comprehensive-assessment-and-care-approach
#15
REVIEW
Osvely Mendez-Guerrero, Anaisa Carranza-Carrasco, Luis Alberto Chi-Cervera, Aldo Torre, Nalu Navarro-Alvarez
Cirrhosis is considered a growing cause of morbidity and mortality, which represents a significant public health problem. Currently, there is no effective treatment to reverse cirrhosis. Treatment primarily centers on addressing the underlying liver condition, monitoring, and managing portal hypertension-related complications, and evaluating the potential for liver transplantation in cases of decompensated cirrhosis, marked by rapid progression and the emergence of complications like variceal bleeding, hepatic encephalopathy, ascites, malnutrition, and more...
March 14, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38594894/a-rare-cause-of-empyema-and-bacteremia-due-to-shewanella-species-in-alcoholic-cirrhosis-patients-a-case-report-and-comprehensive-review-of-literature
#16
JOURNAL ARTICLE
Bohui Qian, Kazuhiro Ishikawa, Tomoaki Nakamura, Katsuhito Kinoshita, Tetsuhiro Masaki, Takahiro Matsuo, Fujimi Kawai, Nobuyoshi Mori
BACKGROUND Shewanella spp. are gram-negative facultative anaerobic, oxidase-positive, motile bacilli that are ubiquitous but commonly occur in seawater and can cause opportunistic infection. Reports on the risk factors for Shewanella infection, its severity, antibiotic susceptibility, and prognosis are limited. This report is of a 78-year-old man with alcoholic cirrhosis presenting with bacteremia and empyema due to infection with Shewanella spp. CASE REPORT A 78-year-old man with alcoholic cirrhosis (Child-Pugh B) presented to our emergency room with a high fever...
April 10, 2024: American Journal of Case Reports
https://read.qxmd.com/read/38592411/portal-vein-thrombosis-state-of-the-art-review
#17
REVIEW
Andrea Boccatonda, Simone Gentilini, Elisa Zanata, Chiara Simion, Carla Serra, Paolo Simioni, Fabio Piscaglia, Elena Campello, Walter Ageno
Background: Portal vein thrombosis (PVT) is a rare disease with an estimated incidence of 2 to 4 cases per 100,000 inhabitants. The most common predisposing conditions for PVT are chronic liver diseases (cirrhosis), primary or secondary hepatobiliary malignancy, major infectious or inflammatory abdominal disease, or myeloproliferative disorders. Methods: PVT can be classified on the basis of the anatomical site, the degree of venous occlusion, and the timing and type of presentation. The main differential diagnosis of PVT, both acute and chronic, is malignant portal vein invasion, most frequently by hepatocarcinoma, or constriction (typically by pancreatic cancer or cholangiocarcinoma)...
March 6, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38592162/the-role-of-transjugular-intrahepatic-portosystemic-shunt-for-the-management-of-ascites-in-patients-with-decompensated-cirrhosis
#18
REVIEW
Giulia Iannone, Enrico Pompili, Clara De Venuto, Dario Pratelli, Greta Tedesco, Maurizio Baldassarre, Paolo Caraceni, Giacomo Zaccherini
The development and progression of ascites represent a crucial event in the natural history of patients with cirrhosis, predisposing them to other complications and carrying a heavy impact on prognosis. The current standard of care for the management of ascites relies on various combinations of diuretics and large-volume paracenteses. Periodic long-term albumin infusions on top of diuretics have been recently shown to greatly facilitate the management of ascites. The insertion of a transjugular intrahepatic portosystemic shunt (TIPS), an artificial connection between the portal and caval systems, is indicated to treat patients with refractory ascites...
February 27, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38590458/delayed-presentation-of-acute-compartment-syndrome-after-isolated-closed-fibular-shaft-fracture-a-case-report
#19
Dimitrios Giotis, Vasileios Panagiotopoulos, Sotiris Plakoutsis, Dimitrios Vardakas, Christos Konstantinidis
Post-traumatic compartment syndrome in the lower extremity has been commonly associated with fractures of the tibia. Only in rare cases, this critical condition might be related to isolated fibular fractures. We present a rare case of delayed onset of acute compartment syndrome after a solitary fracture of the fibula. A 40-year-old man with a history of coagulation disorders due to hepatic cirrhosis was admitted to a neighboring hospital after a car accident with left-sided fractures to ribs 9 and 10 and a transverse fracture in the mid-shaft of the left fibula...
March 2024: Curēus
https://read.qxmd.com/read/38586723/primary-effusion-lymphoma-secondary-to-human-herpesvirus-8-hhv-8-infection-in-an-immunocompetent-host-a-case-report
#20
Sagar Pandey, Ernestine Faye S Tan, Myo Myint Tun, Amulya Bellamkonda, Shwe Yee Htet, Kalendra Kunwar, Madhumati Kalavar
Primary effusion lymphoma (PEL) is a rare, aggressive, mature type of B-cell lymphoma that usually causes malignant, lymphomatous effusions in the absence of a solid mass. This is commonly seen in immunosuppressed individuals such as those with underlying malignancies, human immunodeficiency virus infection (HIV), cirrhosis, and a history of solid organ transplantation who are infected with human herpesvirus 8 (HHV-8). Clinical presentation varies depending on the extent of disease like shortness of breath, abdominal distention, and typical B symptoms like weight loss, fever, and night sweats...
March 2024: Curēus
keyword
keyword
107574
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.